S-Ketamine vs R-Ketamine: Comparing Effects & Uses

If you've been researching ketamine therapy, you've probably encountered terms like "S-ketamine," "R-ketamine," "esketamine," and "arketamine." It's confusing, and the terminology matters more than it might seem at first.

These aren't interchangeable names for the same thing. S-ketamine and R-ketamine are chemically distinct mirror-image molecules with different uses, side effect profiles, and availability. Understanding the difference helps you make sense of your treatment options.

This guide breaks down what you actually need to know: what each form is, what's available to you, and how they compare for people exploring ketamine for depression and other mental health conditions.

What Are S-Ketamine and R-Ketamine?

Ketamine exists as two mirror-image molecules called enantiomers. Think of your left and right hands: both have the same components but are oriented differently in space. This seemingly small distinction creates meaningful differences in how each form works.

S-Ketamine (Esketamine) is the FDA-approved form, sold as a nasal spray called Spravato. It received approval in 2019 for treatment-resistant depression and must be administered at certified clinics with two-hour monitoring after each dose.

R-Ketamine (Arketamine) remains experimental. Early research suggested it might offer longer-lasting effects with fewer side effects, but a controlled clinical trial found it wasn't more effective than placebo for depression. It's not available outside clinical trials.

Racemic ketamine contains both forms in equal 50/50 proportions. This is what most IV clinics and at-home programs use. Originally FDA-approved as an anesthetic in the 1960s, it's now commonly prescribed off-label for depression via IV infusion or sublingual tablets.

How Do They Work Differently?

Both S-ketamine and R-ketamine block NMDA receptors in your brain's glutamate system, a fundamentally different mechanism from traditional antidepressants that work through serotonin. This is why ketamine can produce effects within hours rather than the weeks required by SSRIs.

S-ketamine binds about four times tighter to these receptors. You might assume stronger binding means better results, but research suggests the opposite may be true: racemic ketamine (with both forms) often shows higher response rates than S-ketamine alone in comparative studies. Researchers call this the "potency paradox."

The stronger binding may also explain why S-ketamine causes more pronounced dissociative effects, and why Spravato requires mandatory clinic monitoring.

When ketamine blocks NMDA receptors, it triggers a cascade that can rapidly improve mood: increased glutamate release, activation of pathways that promote new neural connections, and stimulation of brain-derived neurotrophic factor (BDNF). Mental health conditions appear to physically affect brain structures, weakening connections in areas that regulate mood and stress. Ketamine helps rebuild these pathways by promoting synapse formation and enhancing neuroplasticity, your brain's ability to form new neural connections.

This is why many clinicians emphasize pairing ketamine with therapy. The medication opens a window of neuroplasticity; therapeutic support helps you make the most of it. Without that integration, the benefits may fade faster.

Both S-ketamine and R-ketamine activate these processes, but racemic ketamine engages them through both enantiomers working together. For a deeper dive into the mechanics of ketamine, explore our comprehensive guide on ketamine science.

What Does the Research Show?

S-Ketamine (Spravato)

Based on FDA trials, S-ketamine shows:

• Response rates of 27.7–31.6% for treatment-resistant depression
• Rapid onset within 24–48 hours
• Long-term retention of 76% at 2 years for stable responders

These results come from large-scale studies involving thousands of people.

R-Ketamine

Despite promising laboratory research, R-ketamine has not produced comparable results in human clinical trials. The controlled study found that it wasn't superior to placebo, though it was extremely well-tolerated. This disconnect between lab findings and real-world outcomes has limited further development.

Racemic Ketamine

Comparative analyses suggest racemic ketamine may show higher response rates than esketamine in some meta-analyses. However, different delivery methods (IV vs. nasal spray) make direct comparisons complicated.

Side Effects and Safety

S-Ketamine

Common side effects include sedation (48–61% of people), dissociation, and blood pressure elevation. These safety concerns are why mandatory two-hour monitoring at certified facilities is required after each dose.

R-Ketamine

Early research suggests fewer dissociative effects, but since it wasn't more effective than placebo, this tolerability advantage may be moot.

Racemic Ketamine

Side effects involve both enantiomers' effects combined. Safety depends heavily on provider protocols. The American Society of Anesthesiologists issued guidance emphasizing that ketamine for mental health should meet the same safety standards as anesthetics, including trained healthcare professionals.

For all forms, long-term monitoring should include screening for bladder symptoms and cardiovascular effects.

Access and Cost

S-Ketamine (Spravato)

Treatment follows a structured protocol: twice-weekly clinic visits for the first month (eight sessions minimum), then tapering to weekly or biweekly based on your response. Each visit requires treatment at a REMS-certified facility with mandatory two-hour monitoring, blood pressure checks, and stability assessment before you can leave.

Medication costs $761–$1,131 per session, with first-month totals reaching $6,088–$9,048 for medication alone; facility and monitoring fees are billed separately. Insurance coverage typically requires documented failure of at least two antidepressants at adequate doses.

R-Ketamine

Not available outside clinical trials. Given its failure to beat placebo in controlled studies, broader availability may not come.

Racemic Ketamine

More accessible and affordable. Compounded racemic ketamine costs approximately $100–150 per month through various providers. At-home ketamine therapy programs offer sublingual tablets without repeated clinic visits or IV infusions.

Insurance coverage varies significantly. Many plans don't cover off-label use, though some at-home providers have secured insurance partnerships.

How Does Innerwell's Approach Work?

Innerwell uses racemic ketamine with comprehensive clinical oversight. Unlike medication-delivery services with minimal support or clinic programs requiring repeated visits, Innerwell combines at-home convenience with the therapeutic integration that maximizes ketamine's benefits.

Ketamine opens a window of neuroplasticity, but what you do during that window matters. That's why every Innerwell plan includes licensed psychotherapist guidance, not unlicensed guides or minimal check-ins.

The process:

1. Evaluation: A comprehensive virtual psychiatric assessment by licensed providers (Master's or Doctoral level) determines whether ketamine is appropriate, reviews your medical history and current medications, and creates a personalized protocol.
2. Delivery: Once approved, sublingual tablets ship securely to your door with dosing instructions and direct clinician access. No clinic visits, no needle sticks, no IV infusions, just the convenience of treatment in your own space.
3. Preparation and integration: Before your first session, you'll work with a licensed psychotherapist who helps you prepare, set intentions, and understand what to expect. After each session, integration exercises help you process insights and apply them to lasting change.
4. Ongoing monitoring: Your care team tracks progress continuously, adjusting protocols based on your response. Regular check-ins and secure messaging keep you connected to clinical support.

Pricing: Innerwell's insurance partnerships make treatment accessible at a fraction of competitor costs:

• Foundation Plan: $599 with insurance ($998 self-pay) for 8 treatments
• Extended Plan: $1,299 with insurance ($1,999 self-pay) for 24 treatments
• Per-session: As low as $54 with insurance

Available with insurance coverage in California and New York.

Ready to explore ketamine therapy with comprehensive clinical oversight? Take the free assessment to see if Innerwell's approach might work for you.

Which Option Is Right for You?

The short answer: R-ketamine isn't available outside trials. Your real choice is between S-ketamine (Spravato) and racemic ketamine.

Spravato may make sense if:

• You want FDA-approved treatment
• Your insurance covers it well
• You can commit to twice-weekly clinic visits with two-hour monitoring

At-home racemic ketamine may be better if:

• You need flexible scheduling
• You live far from Spravato clinics
• You want therapeutic support built into your treatment
• You find the emerging research on racemic formulations compelling
• You want to avoid repeated clinic visits

What to watch for: Skip providers that lack comprehensive screening, use unlicensed guides, or offer ketamine without mental health follow-up. The medication alone isn't enough; preparation and integration make the difference.

Find out if ketamine therapy is right for you and evaluate your options.

Frequently Asked Questions

Which is more effective: S-ketamine or R-ketamine?

S-ketamine has demonstrated effectiveness in large-scale trials with response rates of 27.7–31.6%. R-ketamine failed to beat placebo in controlled trials despite promising preclinical research. Racemic ketamine (containing both) may show superior results in some comparative analyses, though different delivery methods make direct comparisons complicated.

Can I get R-ketamine treatment?

No. R-ketamine is only available in registered clinical trials and has no legal prescribing pathway otherwise. Your practical options are FDA-approved S-ketamine (Spravato) or off-label racemic ketamine through IV clinics or at-home sublingual programs.

Is at-home ketamine treatment safe?

Safety depends on the provider and protocol. Spravato is legally prohibited from home use due to its REMS requirements. Racemic ketamine can be prescribed for at-home sublingual use when combined with proper clinical oversight: comprehensive screening, licensed clinicians, preparation and integration support, and ongoing monitoring.

How much does ketamine treatment cost?

Spravato costs $761–$1,131 per session for medication alone, with first-month totals reaching $6,088–$9,048 plus separate facility fees. At-home racemic ketamine through Innerwell costs as low as $54 per treatment with insurance, or $83–125 per treatment self-pay, including clinical oversight and therapeutic support.

What does ketamine treatment feel like?

You may experience dissociation (a floating sensation) along with perception changes during treatment. Effects typically peak around 40 minutes and resolve within two hours. Many people find the experience meaningful with proper preparation and intention setting. For details, read about what ketamine therapy feels like.